During the past decade, Hospital Geral de Goiânia conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Geral de Goiânia" #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Geral de Goiânia" are "Crohn's Disease" (1 trials) and "Systemic Lupus Erythematosus" (1 trials). Many other conditions were trialed in "Hospital Geral de Goiânia" in a lesser frequency.

Most popular intervention types in "Hospital Geral de Goiânia" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Belimumab 1 mg/kg" (1 trials), "Belimumab 10 mg/kg" (1 trials), "CCX282-B" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Geral de Goiânia" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Geral de Goiânia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hospital Geral de Goiânia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Geral de Goiânia, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".